Variables · Breast staging sample
EXT¶
종양이 퍼진 정도-원발부위 내 종양침범 또는 인접 기관 내에 직접 침범 유무 · Extension of the primary tumor, within the organ or into an adjacent organ
- Dataset Breast staging sample (유방암 표본 병기)
- Table Cancer registration · 암_공공_병기조사_유방암_DB_암등록
- File
CS_BC_RGST - Type
VARCHAR(3)
Definition¶
Extension of the primary tumor, within the organ or into an adjacent organ.
Codes¶
| Code | 한글 | English |
|---|---|---|
0 |
In situ: noninfiltrating; intraepithelial Intraductal WITHOUT infiltration Lobular neoplasia | In situ: noninfiltrating; intraepithelial Intraductal WITHOUT infiltration Lobular neoplasia |
50 |
Paget disease of nipple WITHOUT underlying tumor | Paget disease of nipple WITHOUT underlying tumor |
70 |
Paget Disease of nipple WITHOUT underlying invasive carcinoma pathologically | Paget Disease of nipple WITHOUT underlying invasive carcinoma pathologically |
100 |
Confined to breast tissue and fat including nipple and/or areola Localized, NOS | Confined to breast tissue and fat including nipple and/or areola Localized, NOS |
110 |
Stated as T1mi with no other information on extension | Stated as T1mi with no other information on extension |
120 |
Stated as T1a with no other information on extension | Stated as T1a with no other information on extension |
130 |
Stated as T1b with no other information on extension | Stated as T1b with no other information on extension |
140 |
Stated as T1c with no other information on extension | Stated as T1c with no other information on extension |
170 |
Stated as T1 [NOS] with no other information on extension or size | Stated as T1 [NOS] with no other information on extension or size |
180 |
Stated as T2 with no other information on extension or size | Stated as T2 with no other information on extension or size |
190 |
Stated as T3 with no other information on extension or size | Stated as T3 with no other information on extension or size |
200 |
Invasion of subcutaneous tissue Local infiltration of dermal lymphatics adjacent to primary tumor involving skin by direct extension Skin infiltration of primary breast including skin of nipple and/or areola | Invasion of subcutaneous tissue Local infiltration of dermal lymphatics adjacent to primary tumor involving skin by direct extension Skin infiltration of primary breast including skin of nipple and/or areola |
300 |
Attachment or fixation to pectoral muscle(s) or underlying tissue Deep fixation Invasion of (or fixation to) pectoral fascia or muscle | Attachment or fixation to pectoral muscle(s) or underlying tissue Deep fixation Invasion of (or fixation to) pectoral fascia or muscle |
400 |
Invasion of (or fixation to): Chest wall Intercostal or serratus anterior muscle(s) Rib(s) See codes 610 (obsolete), 612-615, and 620 (obsolete) for combinations with this code | Invasion of (or fixation to): Chest wall Intercostal or serratus anterior muscle(s) Rib(s) See codes 610 (obsolete), 612-615, and 620 (obsolete) for combinations with this code |
410 |
Stated as T4a with no other information on extension | Stated as T4a with no other information on extension |
512 |
Extensive skin involvement, including: Satellite nodule(s) in skin of primary breast Ulceration of skin of breast | Extensive skin involvement, including: Satellite nodule(s) in skin of primary breast Ulceration of skin of breast |
514 |
Any of the following conditions described as involving less than one-third (33%) of the breast WITHOUT a stated diagnosis of inflammatory carcinoma WITH or WITHOUT dermal lymphatic infiltration: Edema of skin En cuirasse Erythema Inflammation of skin Peau d'orange ("pigskin") | Any of the following conditions described as involving less than one-third (33%) of the breast WITHOUT a stated diagnosis of inflammatory carcinoma WITH or WITHOUT dermal lymphatic infiltration: Edema of skin En cuirasse Erythema Inflammation of skin Peau d'orange ("pigskin") |
516 |
514 + 512 | 514 + 512 |
518 |
Any of the following conditions described as involving one third (33%) or more but less than or equal to half (50%) of the breast WITHOUT a stated diagnosis of inflammatory carcinoma WITH or WITHOUT dermal lymphatic infiltration: Edema of skin En cuirasse Erythema Inflammation of skin Peau d'orange ("pigskin") | Any of the following conditions described as involving one third (33%) or more but less than or equal to half (50%) of the breast WITHOUT a stated diagnosis of inflammatory carcinoma WITH or WITHOUT dermal lymphatic infiltration: Edema of skin En cuirasse Erythema Inflammation of skin Peau d'orange ("pigskin") |
519 |
518 + 512 | 518 + 512 |
520 |
Any of the following conditions described as involving more than 50% of the breast WITHOUT a stated diagnosis of inflammatory carcinoma WITH or WITHOUT dermal lymphatic infiltration: Edema of skin En cuirasse Erythema Inflammation of skin Peau d'orange ("pigskin") | Any of the following conditions described as involving more than 50% of the breast WITHOUT a stated diagnosis of inflammatory carcinoma WITH or WITHOUT dermal lymphatic infiltration: Edema of skin En cuirasse Erythema Inflammation of skin Peau d'orange ("pigskin") |
575 |
520 + 512 | 520 + 512 |
580 |
Any of the following conditions with amount or percent of breast involvement not stated and WITHOUT a stated diagnosis of inflammatory carcinoma WITH or WITHOUT dermal lymphatic infiltration: Edema of skin En cuirasse Erythema Inflammation of skin Peau d'orange ("pigskin") | Any of the following conditions with amount or percent of breast involvement not stated and WITHOUT a stated diagnosis of inflammatory carcinoma WITH or WITHOUT dermal lymphatic infiltration: Edema of skin En cuirasse Erythema Inflammation of skin Peau d'orange ("pigskin") |
585 |
580 + 512 | 580 + 512 |
600 |
Diagnosis of inflammatory carcinoma WITH a clinical description of inflammation, erythema, edema, peau d'orange, etc., involving less than one-third (33%) of the skin of the breast, WITH or WITHOUT dermal lymphatic infiltration | Diagnosis of inflammatory carcinoma WITH a clinical description of inflammation, erythema, edema, peau d'orange, etc., involving less than one-third (33%) of the skin of the breast, WITH or WITHOUT dermal lymphatic infiltration |
605 |
Stated as T4b with no other information on extension | Stated as T4b with no other information on extension |
612 |
Any of (512-516) + 400 | Any of (512-516) + 400 |
613 |
Any of (518-519) + 400 | Any of (518-519) + 400 |
615 |
Any of (520-585) + 400 | Any of (520-585) + 400 |
680 |
Stated as T4c with no other information on extension | Stated as T4c with no other information on extension |
725 |
Diagnosis of inflammatory carcinoma WITH a clinical description of inflammation, erythema, edema, peau d'orange, etc., involving one-third (33%) or more but less than or equal to one-half (50%) of the skin of the breast, WITH or WITHOUT dermal lymphatic infiltration | Diagnosis of inflammatory carcinoma WITH a clinical description of inflammation, erythema, edema, peau d'orange, etc., involving one-third (33%) or more but less than or equal to one-half (50%) of the skin of the breast, WITH or WITHOUT dermal lymphatic infiltration |
730 |
Diagnosis of inflammatory carcinoma WITH a clinical description of inflammation, erythema, edema, peau d'orange, etc., involving more than one-half (50%) of the skin of the breast, WITH or WITHOUT dermal lymphatic infiltration | Diagnosis of inflammatory carcinoma WITH a clinical description of inflammation, erythema, edema, peau d'orange, etc., involving more than one-half (50%) of the skin of the breast, WITH or WITHOUT dermal lymphatic infiltration |
750 |
Diagnosis of inflammatory carcinoma WITH a clinical description of inflammation, erythema, edema, peau d'orange, etc., but percent of involvement not stated, WITH or WITHOUT dermal lymphatic infiltration. Note: If percentage is known, code to 600, 725, or 730. Diagnosis of inflammatory carcinoma WITHOUT a clinical description of inflammation, erythema, edema, peau d'orange, etc., WITH or WITHOUT dermal lymphatic infiltration Inflammatory carcinoma, NOS | Diagnosis of inflammatory carcinoma WITH a clinical description of inflammation, erythema, edema, peau d'orange, etc., but percent of involvement not stated, WITH or WITHOUT dermal lymphatic infiltration. Note: If percentage is known, code to 600, 725, or 730. Diagnosis of inflammatory carcinoma WITHOUT a clinical description of inflammation, erythema, edema, peau d'orange, etc., WITH or WITHOUT dermal lymphatic infiltration Inflammatory carcinoma, NOS |
780 |
Stated as T4d with no other information on extension | Stated as T4d with no other information on extension |
790 |
State as T4 [NOS] with no other information on extension | State as T4 [NOS] with no other information on extension |
950 |
No evidence of primary tumor | No evidence of primary tumor |
999 |
Unknown; extension not stated Primary tumor cannot be assessed Not documented in patient record | Unknown; extension not stated Primary tumor cannot be assessed Not documented in patient record |
The catalog records these codes as valid from 2012 through 2019.
Catalog note¶
종양이 퍼진 정도-원발부위 내 종양침범 또는 인접 기관 내에 직접 침범 유무
예) 400 → Extension through wall, NOS Invasion through muscularis propria or muscularis, NOS Perimuscular tissue invaded Subserosal tissue/(sub)serosal fat invaded
The Korean text is from the portal data catalog for this 표본 병기 database, downloaded 30 October 2026 (국가암데이터센터_암공공_표본_병기_유방암_261030113608.xlsx). The English is a translation for this site. The catalog says that code values beyond this sheet are on the Health Insurance Review and Assessment Service open-data system.